Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,7-dimethylxanthine
1. 1,7-dimethylxanthine
2. 611-59-6
3. P-xanthine
4. 1h-purine-2,6-dione, 3,7-dihydro-1,7-dimethyl-
5. 1,7-dimethyl-3h-purine-2,6-dione
6. 3,7-dihydro-1,7-dimethyl-1h-purine-2,6-dione
7. Xanthine, 1,7-dimethyl-
8. Caffeine Impurity F
9. 1,7-dimethyl-3,7-dihydro-1h-purine-2,6-dione
10. 1,7-dimethyl-xanthine
11. Chembl1158
12. Chebi:25858
13. Nsc-400018
14. Q3565y41v7
15. 1,7-dimethyl-2,3,6,7-tetrahydro-1h-purine-2,6-dione
16. Einecs 210-271-9
17. Nsc 400018
18. Brn 0197907
19. Unii-q3565y41v7
20. Mfcd00005727
21. Paraxanthine(72%)
22. Spectrum2_001733
23. Spectrum3_000774
24. Spectrum4_001207
25. Spectrum5_001506
26. Lopac-d-5385
27. Paraxanthine [inci]
28. Dsstox_cid_30853
29. Dsstox_gsid_52281
30. Lopac0_000389
31. Bspbio_002448
32. Kbiogr_001614
33. 5-26-13-00554 (beilstein Handbook Reference)
34. Mls000859929
35. Divk1c_000081
36. Schembl232702
37. Spectrum2300170
38. Spbio_001806
39. Schembl4651937
40. Dtxsid2052281
41. Hms500e03
42. Kbio1_000081
43. Kbio3_001668
44. Ninds_000081
45. Hms2231k19
46. Hms3261m19
47. Hms3370a12
48. Zinc120234
49. Tox21_303803
50. Tox21_500389
51. Bdbm50042210
52. Ccg-39489
53. Nsc400018
54. 1,7-dimethylxanthine, ~98%, Solid
55. Akos015913484
56. Cs-w017214
57. Hy-w016498
58. Lp00389
59. Sdccgsbi-0050376.p003
60. 1,7-dimethylxanthine-[13c4,15n3]
61. Idi1_000081
62. Ncgc00015347-01
63. Ncgc00015347-02
64. Ncgc00015347-03
65. Ncgc00015347-04
66. Ncgc00015347-05
67. Ncgc00015347-06
68. Ncgc00015347-07
69. Ncgc00015347-09
70. Ncgc00093817-01
71. Ncgc00093817-02
72. Ncgc00093817-03
73. Ncgc00093817-04
74. Ncgc00261074-01
75. Ncgc00357087-01
76. As-64037
77. Caffeine Impurity F [ep Impurity]
78. Cas-611-59-6
79. Smr000326790
80. Db-005072
81. Eur J Pharmacol 179: 295 (1990)
82. 1h-purine-2, 3,7-dihydro-1,7-dimethyl-
83. 3-(4-methoxy-1-naphthyl)acrylicacid
84. D5696
85. Eu-0100389
86. Ft-0632550
87. Ft-0673516
88. D 5385
89. D94772
90. 1,7-dimethylxanthine 100 Microg/ml In Methanol
91. A853055
92. Q419223
93. Sr-01000075184
94. 1,7-dimethyl-3,7-dihydro-1h-purine-2,6-dione #
95. 1,7-dimethylxanthine 100 Microg/ml In Acetonitrile
96. Sr-01000075184-1
97. Brd-k24084088-001-02-2
98. Brd-k24084088-001-06-3
99. Caffeine Monohydrate Impurity F [ep Impurity]
100. 1,7-dimethyl-3,7-dihydro-1h-purine-2,6-dione (paraxanthine; 1,7-dimethylxanthine)
101. Paraxanthine Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
102. 1,7-dimethyl-3,7-dihydro- 1h-purine-2,6-dione (caffeine Impurity F), Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 180.16 g/mol |
|---|---|
| Molecular Formula | C7H8N4O2 |
| XLogP3 | -0.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 180.06472551 g/mol |
| Monoisotopic Mass | 180.06472551 g/mol |
| Topological Polar Surface Area | 67.2 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 267 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Paraxanthine has known human metabolites that include 1,7-Dimethyluric acid and 1-Methylxanthine.
Paraxanthine is a known human metabolite of caffeine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Digital Content 
NEWS #PharmaBuzz
ANALYTICAL
ABOUT THIS PAGE
A Paraxanthine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paraxanthine, including repackagers and relabelers. The FDA regulates Paraxanthine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paraxanthine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Paraxanthine supplier is an individual or a company that provides Paraxanthine active pharmaceutical ingredient (API) or Paraxanthine finished formulations upon request. The Paraxanthine suppliers may include Paraxanthine API manufacturers, exporters, distributors and traders.
Paraxanthine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Paraxanthine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Paraxanthine GMP manufacturer or Paraxanthine GMP API supplier for your needs.
A Paraxanthine CoA (Certificate of Analysis) is a formal document that attests to Paraxanthine's compliance with Paraxanthine specifications and serves as a tool for batch-level quality control.
Paraxanthine CoA mostly includes findings from lab analyses of a specific batch. For each Paraxanthine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Paraxanthine may be tested according to a variety of international standards, such as European Pharmacopoeia (Paraxanthine EP), Paraxanthine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Paraxanthine USP).
LOOKING FOR A SUPPLIER?
